• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗皮肤癌的透明质酸/阳离子固体脂质纳米颗粒/小干扰RNA经皮复合物

Transdermal hyaluronate/cationic solid lipid nanoparticle/siRNA complex for the treatment of skin cancer.

作者信息

Piao Zhengyu, Kim Mungu, Huh Jin, Hahn Sei Kwang

机构信息

Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk 37673, Republic of Korea.

Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk 37673, Republic of Korea.

出版信息

J Control Release. 2025 Sep 10;385:113967. doi: 10.1016/j.jconrel.2025.113967. Epub 2025 Jun 23.

DOI:10.1016/j.jconrel.2025.113967
PMID:40562235
Abstract

Lipid nanoparticles (LNPs) are widely recognized for their potential in drug delivery. However, they exhibit significant limitations in stability and targeting. In this study, we designed a target-specific siRNA delivery system by coating hyaluronate (HA) onto cationic solid lipid nanoparticles (CSLNs). The angiogenesis-inhibiting siVEGF formed a stable nanoscale complex for the targeted delivery to skin cancer tissue. The nucleic acid drug in the HA/CSLN/siVEGF complex was electrostatically coated on the surface of CSLN, enabling high drug loading capacity. Moreover, HA appeared to serve a dual purpose in this design by targeting to cancer cells and facilitating effective transdermal delivery. The optimized HA/CSLN/siVEGF complex resulted in facilitated transdermal delivery, effective tumor targeting, and significantly reduced VEGF mRNA levels, leading to tumor growth inhibition. Taken together, the HA/CSLN complex would be successfully harnessed as a transdermal target-specific delivery carrier of siRNA for cancer therapy.

摘要

脂质纳米颗粒(LNPs)因其在药物递送方面的潜力而被广泛认可。然而,它们在稳定性和靶向性方面存在显著局限性。在本研究中,我们通过将透明质酸(HA)包覆在阳离子固体脂质纳米颗粒(CSLNs)上,设计了一种靶向特异性siRNA递送系统。抑制血管生成的siVEGF形成了一种稳定的纳米级复合物,用于靶向递送至皮肤癌组织。HA/CSLN/siVEGF复合物中的核酸药物通过静电作用包覆在CSLN表面,从而实现高药物负载量。此外,HA在该设计中似乎具有双重作用,既能靶向癌细胞,又能促进有效的透皮递送。优化后的HA/CSLN/siVEGF复合物实现了促进透皮递送、有效肿瘤靶向,并显著降低了VEGF mRNA水平,从而抑制肿瘤生长。综上所述,HA/CSLN复合物将成功用作siRNA的透皮靶向特异性递送载体用于癌症治疗。

相似文献

1
Transdermal hyaluronate/cationic solid lipid nanoparticle/siRNA complex for the treatment of skin cancer.用于治疗皮肤癌的透明质酸/阳离子固体脂质纳米颗粒/小干扰RNA经皮复合物
J Control Release. 2025 Sep 10;385:113967. doi: 10.1016/j.jconrel.2025.113967. Epub 2025 Jun 23.
2
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.使用经TAT-透明质酸功能化的负载小干扰RNA的壳聚糖乳酸纳米颗粒阻断CD73可增强阿霉素在体外和体内对癌细胞的细胞毒性作用。
Int J Biol Macromol. 2021 Sep 1;186:849-863. doi: 10.1016/j.ijbiomac.2021.07.034. Epub 2021 Jul 7.
3
Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy.癌细胞膜伪装的pH响应性纳米颗粒用于增强siRNA效应和协同抗肿瘤治疗。
J Nanobiotechnology. 2025 Jul 1;23(1):471. doi: 10.1186/s12951-025-03508-6.
4
SOX9 siRNA Loaded Lipid Nanoparticles Actively Targeted: Formulation, Delivery, and Antitumor Effect on Colorectal Cancer and .负载SOX9小干扰RNA的脂质纳米颗粒的主动靶向:制剂、递送及其对结直肠癌的抗肿瘤作用
Mol Pharm. 2025 Sep 1;22(9):5346-5360. doi: 10.1021/acs.molpharmaceut.5c00272. Epub 2025 Jul 27.
5
Powder-attached microneedles for the stable and effective transdermal delivery of clinically validated mRNA-LNP vaccine.用于临床验证的mRNA-LNP疫苗稳定有效透皮递送的附粉微针
Eur J Pharm Biopharm. 2025 Sep;214:114811. doi: 10.1016/j.ejpb.2025.114811. Epub 2025 Jul 19.
6
Engineered Extracellular Vesicles for Tumor-Targeted Delivery of Therapeutic siRNA for Lung Cancer Therapy.用于肺癌治疗的治疗性siRNA肿瘤靶向递送的工程化细胞外囊泡
ACS Biomater Sci Eng. 2025 Jul 14;11(7):4206-4218. doi: 10.1021/acsbiomaterials.5c00434. Epub 2025 Jun 10.
7
Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma.低频超声介导的血脑屏障开放可实现脂质纳米颗粒RNA对胶质母细胞瘤的无创递送。
J Control Release. 2025 Jul 7;385:114018. doi: 10.1016/j.jconrel.2025.114018.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.探索透明质酸包被的聚合物纳米颗粒在精准给药增强癌症治疗、克服耐药性和重塑肿瘤微环境方面的潜力。
Curr Med Chem. 2024 Apr 3. doi: 10.2174/0109298673302510240328050115.
10
Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells.脂质纳米颗粒中的可电离脂质化学性质决定了对肝星状细胞的递送效率。
J Control Release. 2025 Jul 21;385:114055. doi: 10.1016/j.jconrel.2025.114055.